# Citius Pharmaceuticals, Inc.: Form 8-K, filed Apr 18, 2025

- Company: [Citius Pharmaceuticals, Inc.](/companies/ctxr.md) (CIK 1506251)
- Form: 8-K
- Filed: 2025-04-18
- Accepted by EDGAR: Apr 18, 2025, 16:05 ET
- Period: 2025-04-16
- Accession: 0001213900-25-033366
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1506251/000121390025033366/ea0238657-8k_citius.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1506251/000121390025033366/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1506251/000121390025033366/ea0238657-8k_citius.htm

Filed Apr 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-033366. Last ingested by Listed: Oct 26, 2026, 16:06 ET. No prices; not investment advice.